Skip to navigationSkip to content

Podcast: Letting people sell their kidneys solved Iran’s organ shortage. Should the US do the same?

Adam Abernathy frowns as a nurse puts an IV in his arm as he waits to receive a donated kidney as part of a five-way organ transplant swap in New York, August 1, 2012. Abernathy's partner David Ferguson donated a kidney for transplant to a stranger while at the same time someone else donated a kidney to Abernathy as part of chain of kidney donations that allowed five people to receive a transplanted kidney over a two day period. The health dangers for kidney donors is believed to be low. The risk of death from the surgery is 1 in 1,700, according to the National Kidney Foundation, and life expectancy is said to be unchanged with one kidney. Picture taken August 1, 2012.
Reuterse/Keith Bedford
Taking the sting out of organ donation.
  • Tim Fernholz
By Tim Fernholz

Senior reporter

Published Last updated This article is more than 2 years old.

Update, 6.12.15: The podcast has now launched, and you can listen or subscribe to Actuality in iTunes.

Quartz and Marketplace are collaborating on a new podcast. It’s still in preview mode, but we’re releasing the latest episode for your enjoyment and feedback.

This week, we look at a thorny public health problem: facing a shortage of living organ donors, should we let people sell their organs?

Hosts Tim Fernholz and Sabri Ben-Achour are joined by bioethicist Sigrid Fry-Revere, an advocate for living donors, and Dr. David Axelrod, the chief of transplant surgery at Dartmouth Hitchock medical center.

Please send us your thoughts on the episode and suggestions for what we should discuss in the future. You also can listen to preview episodes on digital piracysuper batteries and ocean extinction, and, soon, so very soon, subscribe to future episodes wherever fine podcasts are distributed.

📬 Need to Know: Davos

A daily dispatch from the annual meeting of the World Economic Forum.

By providing your email, you agree to the Quartz Privacy Policy.